Relief for Novartis’s Entresto In India Challenge But More To Come?

Novartis secures injunction order against alleged infringers of heart failure therapy Entresto in India. Court also makes key observations around the “scientific opinion”, which had gone in favor of challenger Natco.

patent
Win For Novartis In Entresto India Case • Source: Alamy

Novartis AG has a secured an important win, at least for now, in a case pertaining to the alleged infringement of the patent for its blockbuster heart failure therapy Entresto (sacubitril/valsartan) in India.

In a recent injunction, the Delhi High Court restrained the local companies Natco Pharma Limited, Torrent Pharmaceuticals Ltd.,...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia